Author:
Wefel Jeffrey S.,Armstrong Terri A.,Kohli Sadhna
Reference196 articles.
1. Meyers CA, Hess KR, Yung WK, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000 Feb;18 3:646–50.
2. Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer 2003 Feb 1;97 3:649–56.
3. Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol. 2003 Apr;5 2:89–95.
4. Meyers CA. Issues of quality of life in neuro-oncology. In: Vecht CJ, editor. Handbook of clinical neurology, neuro-oncology, part 1 brain tumors: principles of biology, diagnosis and therapy.Vol. 23. Amsterdam: Elsevier Science B.V.; 1997. pp. 389–409.
5. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006 Mar 10;24 8:1305–09.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Family Psychotherapy for Seizure Disorders;Psychotherapy for Families after Brain Injury;2014